Compare CAPL & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAPL | MLAB |
|---|---|---|
| Founded | 1992 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Industrial Machinery/Components |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 889.1M | 719.9M |
| IPO Year | 2012 | 1995 |
| Metric | CAPL | MLAB |
|---|---|---|
| Price | $21.45 | $127.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $117.50 |
| AVG Volume (30 Days) | 24.4K | ★ 89.9K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 9.74% | 0.50% |
| EPS Growth | 96.15 | ★ 436.11 |
| EPS | ★ 0.78 | 0.49 |
| Revenue | ★ $1,869,806,000.00 | N/A |
| Revenue This Year | $20.96 | $2.14 |
| Revenue Next Year | $15.62 | $6.45 |
| P/E Ratio | ★ $27.64 | $261.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.78 | $69.43 |
| 52 Week High | $24.63 | $144.35 |
| Indicator | CAPL | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 39.61 | 49.61 |
| Support Level | $21.28 | $89.77 |
| Resistance Level | $21.75 | $132.70 |
| Average True Range (ATR) | 0.39 | 5.03 |
| MACD | 0.02 | -1.26 |
| Stochastic Oscillator | 26.67 | 15.89 |
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments, namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.